tiprankstipranks
Trending News
More News >
Community Health (CYH)
NYSE:CYH

Community Health (CYH) AI Stock Analysis

Compare
409 Followers

Top Page

CY

Community Health

(NYSE:CYH)

Rating:57Neutral
Price Target:
$4.50
▲( 22.62% Upside)
Community Health's overall stock score reflects financial challenges with negative net income and high leverage. Technical indicators suggest short-term bullish momentum, but valuation remains a concern. Earnings call insights and corporate events show positive strategic steps but ongoing operational challenges require addressing for long-term improvement.
Positive Factors
Asset Divestitures
CYH announced an agreement to sell 80% of its ownership interest in Cedar Park Regional Medical Center to Ascension Health for proceeds of $460MM, which is viewed as a positive deal as it was able to sell these assets at a solid valuation.
Financial Health
The divestitures will slightly reduce leverage, which is beneficial for the company's financial health.
Negative Factors
Legislative Risks
The overall risk/reward is seen as unfavorable due to legislative risks and potential for slowing fundamentals.
Medicaid Funding
Analyst perceives increased risk that new Medicaid funding will not be approved, reflecting a 50% probability of approval in their model.

Community Health (CYH) vs. SPDR S&P 500 ETF (SPY)

Community Health Business Overview & Revenue Model

Company DescriptionCommunity Health Systems, Inc. (CYH) is a leading operator of general acute care hospitals in the United States. The company provides healthcare services through a network of hospitals and affiliated outpatient facilities and physicians. Focused on offering a comprehensive range of medical services, Community Health Systems operates in both urban and rural markets, aiming to deliver quality healthcare solutions to various communities across the nation.
How the Company Makes MoneyCommunity Health Systems generates revenue primarily through the operation of its hospitals and associated healthcare facilities. The company's key revenue streams include patient services provided in inpatient and outpatient settings, which are reimbursed through government programs such as Medicare and Medicaid, as well as private health insurance companies. Additionally, CYH earns income from its network of employed physicians and ancillary services like laboratory testing, imaging, and rehabilitation. Strategic partnerships with local healthcare providers and continuous efforts to optimize operational efficiencies also contribute to the company's financial performance.

Community Health Financial Statement Overview

Summary
Community Health is experiencing financial challenges, particularly highlighted by its negative net income and equity. While revenue shows modest growth, profitability and leverage are areas of concern. The company needs to address its high debt levels and improve operational efficiency to return to profitability. Positive operating cash flows provide a foundation for improvement, but strategic financial restructuring is necessary to ensure long-term stability and growth.
Income Statement
45
Neutral
The company's revenue has shown marginal growth over the years, with a TTM revenue of $12.654 billion. However, the net income has turned negative in recent years, resulting in a net loss. This is concerning as it indicates declining profitability, despite the gross profit margin of 37.08% and EBITDA margin of 8.32% in the TTM period. The EBIT margin stands at 4.78%, showing operational challenges. While revenue growth is a positive sign, the company's profitability metrics need improvement to enhance financial stability.
Balance Sheet
30
Negative
The balance sheet reveals significant financial distress, marked by negative stockholders' equity, which indicates insolvency. The debt-to-equity ratio is not calculable due to the negative equity, but the high total debt of $12.1 billion in the TTM period reflects leverage concerns. Return on equity is negative due to the net loss, and the equity ratio is also skewed by negative equity. Overall, the company's balance sheet highlights substantial financial risk with a need for restructuring.
Cash Flow
55
Neutral
Operating cash flow has been positive, with a TTM figure of $504 million, indicating some level of cash generation. However, the free cash flow, although positive at $152 million, has seen fluctuations, with a notable improvement from previous negative periods. The free cash flow to net income ratio is not favorable due to the net loss, but the operating cash flow to net income ratio is positive, showing the company can generate cash despite net losses. Cash flow management needs to focus on consistent positive free cash flow.
Breakdown
TTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
12.65B12.63B12.49B12.21B12.37B11.79B
Gross Profit
4.69B10.69B5.08B4.91B5.08B4.42B
EBIT
605.00M542.00M957.00M821.00M1.40B1.13B
EBITDA
1.09B1.07B1.54B1.74B1.93B2.02B
Net Income Common Stockholders
-487.00M-516.00M-133.00M179.00M368.00M511.00M
Balance SheetCash, Cash Equivalents and Short-Term Investments
431.00M37.00M38.00M118.00M507.00M1.68B
Total Assets
13.89B14.05B14.46B14.67B15.22B16.01B
Total Debt
11.98B12.10B12.17B12.39B12.82B12.88B
Net Debt
11.55B12.06B12.14B12.27B12.31B11.21B
Total Liabilities
15.22B15.37B15.28B15.40B16.03B17.06B
Stockholders Equity
-1.92B-1.91B-1.39B-1.37B-1.37B-1.63B
Cash FlowFree Cash Flow
152.00M120.00M-257.00M-124.00M-603.00M1.74B
Operating Cash Flow
504.00M480.00M210.00M300.00M-131.00M2.18B
Investing Cash Flow
267.00M-275.00M-26.00M-259.00M-524.00M177.00M
Financing Cash Flow
-388.00M-206.00M-264.00M-430.00M-514.00M-895.00M

Community Health Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price3.67
Price Trends
50DMA
2.96
Positive
100DMA
3.08
Positive
200DMA
3.88
Negative
Market Momentum
MACD
0.32
Negative
RSI
56.69
Neutral
STOCH
26.17
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CYH, the sentiment is Neutral. The current price of 3.67 is above the 20-day moving average (MA) of 3.47, above the 50-day MA of 2.96, and below the 200-day MA of 3.88, indicating a neutral trend. The MACD of 0.32 indicates Negative momentum. The RSI at 56.69 is Neutral, neither overbought nor oversold. The STOCH value of 26.17 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for CYH.

Community Health Risk Analysis

Community Health disclosed 38 risk factors in its most recent earnings report. Community Health reported the most risks in the “Finance & Corporate” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Community Health Peers Comparison

Overall Rating
UnderperformOutperform
Sector (53)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$1.04B25.378.37%3.71%1.32%
CYCYH
57
Neutral
$514.92M39.18%1.05%-288.07%
AMAMN
53
Neutral
$795.17M18.62-21.08%-18.13%-215.78%
53
Neutral
$5.14B3.23-45.01%2.85%17.55%-0.69%
52
Neutral
$530.60M-12.03%12.19%-1.59%
49
Neutral
$517.51M-22.81%-1.08%-65.84%
47
Neutral
$443.23M-4.00%-29.16%-140.16%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CYH
Community Health
3.67
0.05
1.38%
AMN
AMN Healthcare Services
20.77
-34.50
-62.42%
CCRN
Cross Country Healthcare
13.52
-1.34
-9.02%
HCSG
Healthcare Services
14.20
3.47
32.34%
INNV
InnovAge Holding
3.93
-0.09
-2.24%
EHAB
Enhabit, Inc
10.22
1.13
12.43%

Community Health Earnings Call Summary

Earnings Call Date:Apr 23, 2025
(Q1-2025)
|
% Change Since: 51.03%|
Next Earnings Date:Jul 23, 2025
Earnings Call Sentiment Neutral
The earnings call for Community Health Systems reflected a balanced sentiment. While the company reported growth in admissions, successful divestitures, and strategic investments, challenges included a decline in surgical volumes, unfavorable payer mix, and rising specialist fees.
Q1-2025 Updates
Positive Updates
Same-Store Admissions and Revenue Growth
Same-store admissions increased by 4%, same-store adjusted admissions by 2.6%, and same-store net operating revenues increased by 3.1% in the first quarter of 2025.
Progress in Divestiture and Debt Reduction
Community Health Systems completed divestitures of ShorePoint Health System and Lake Norman Regional Medical Center, receiving $544 million in proceeds. Plans to sell 80% interest in Cedar Park Regional Medical Center for $460 million are underway.
Debt Refinancing Initiatives
Announced issuance of $700 million in new 10.75% senior secured notes due 2033 to redeem $700 million of outstanding 8% senior secured notes due 2027, improving the company's maturity profile.
Operational Improvements and Strategic Investments
Investments in acute care, ambulatory services, and innovation, including AI and emerging technologies, are advancing patient care and operational efficiency.
Strong Demand in Key Areas
Strong EMS volumes and gains in trauma, primary care, and surgical specialist visits noted. Investments in cardiac services and robotic surgery pay off with growth in these areas.
Negative Updates
Decline in Surgical Volumes
Same-store surgeries down 3% in the first quarter of 2025, attributed partly to flu impact and consumer behavior regarding deductibles.
Unfavorable Payer and Acuity Mix
Same-store net revenue per adjusted admission increased only 0.5% year over year due to unfavorable shifts in payer and acuity mix, and declining Medicaid rates.
Continued Challenges with Medical Specialist Fees
Medical specialist fees increased by 9%, with anesthesiology being the primary area of cost pressure.
Delays in State Supplemental Program Payments
Delays in payments under certain state supplemental programs affected cash flow, although progress is being made to meet annual guidance.
Company Guidance
During the first quarter of fiscal year 2025, Community Health Systems, Inc. reported a 4% increase in same-store admissions, a 2.6% rise in same-store adjusted admissions, and a 3.1% increase in net operating revenues on a same-store basis. The growth was attributed to a stronger flu season and strategic initiatives such as capacity management and service line development. Adjusted EBITDA for the quarter was $376 million, with a margin of 11.9%. The company recorded gross proceeds of $544 million from divestitures and anticipates over $1 billion from additional sales, which will be used to reduce debt. Additionally, Community Health Systems refinanced $700 million in senior secured notes and initiated a cash tender offer for $626 million in unsecured notes to improve its maturity profile. The company maintained its financial guidance for 2025, with potential divestitures and state supplemental program approvals potentially providing upside to the current outlook.

Community Health Corporate Events

Executive/Board ChangesShareholder MeetingsBusiness Operations and Strategy
Community Health Stockholders Approve Key Proposals at Meeting
Positive
May 14, 2025

At the Annual Meeting on May 13, 2025, Community Health Systems, Inc. stockholders approved several key proposals, including the amendment and restatement of the 2009 Stock Option and Award Plan and a Certificate of Amendment for officer exculpation under Delaware law. The meeting also saw the election of directors, approval of executive compensation, and ratification of Deloitte & Touche LLP as the independent auditor for 2025, reflecting shareholder support for the company’s strategic and governance initiatives.

The most recent analyst rating on (CYH) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on Community Health stock, see the CYH Stock Forecast page.

Private Placements and Financing
Community Health Completes $700M Senior Secured Notes Sale
Neutral
May 9, 2025

On May 9, 2025, Community Health Systems, Inc. completed the sale and issuance of $700 million in 10.750% Senior Secured Notes due 2033, using the proceeds to redeem its outstanding 8.000% Senior Secured Notes due 2027. The company also amended the indenture governing its 6.875% Senior Unsecured Notes due 2028, removing several restrictive covenants and provisions, which could impact its financial flexibility and operations.

Private Placements and Financing
Community Health Announces Early Tender Results for Notes
Neutral
May 7, 2025

On May 7, 2025, Community Health Systems, Inc. announced the early tender results of its cash tender offer for its 6.875% Senior Unsecured Notes due 2028. By the early tender deadline on May 6, 2025, approximately 93.32% of the outstanding notes were validly tendered and accepted for purchase, with payment expected on May 8, 2025. The company also received the necessary consent from note holders to adopt proposed amendments to the notes’ indenture, which will be enacted through a supplemental indenture on the early settlement date.

M&A TransactionsBusiness Operations and StrategyFinancial Disclosures
Community Health Reports Q1 2025 Financial Results
Neutral
Apr 23, 2025

On April 23, 2025, Community Health Systems, Inc. reported its financial results for the first quarter ending March 31, 2025, showing net operating revenues of $3.159 billion and a reduced net loss of $13 million compared to the same period in 2024. The company experienced growth in same-store admissions and adjusted admissions, attributed to strong demand for services, and completed several divestitures to reduce debt. Despite challenges in the healthcare sector, the company remains optimistic about its strategic positioning for long-term success.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.